Class ITerminatedD-1277-2014
Drug recall · May 7, 2014
Adipotrim XT recall
Why: Marketed Without an Approved NDA/ANDA: FDA lab results found undeclared API Fluoxetine in this dietary supplement.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Adipotrim XT, New Powerful Formula, 30 rapid release capsules per bottle, Dietary Supplement, www.adipotrim.com.
- Lots / codes
Lot #: 052012, Exp 10/2015
- Quantity
- 1,146 bottles
- Company
- Deseo Rebajar, Fajardo, PR
- Distribution
- Nationwide and Puerto Rico
- Initiated
- November 7, 2013 · Voluntary: Firm initiated
- Classified
- April 25, 2014
- Reported
- May 7, 2014
- Ended
- May 3, 2017
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.